Mon panier

TGF-beta 3

TGF-beta 3 Informations sur la molécule

Nom anglaisTransforming growth factor beta 3Nombre de médicaments commercialisés0
Nombre de médicaments cliniques3Alias de la cibleTransforming Growth Factor beta3,TGFB3,LAP,Prepro-Transforming Growth Factor Beta-3,TGF-Beta3,Transforming Growth Factor, Beta 3,ARVD1,LDS5,Arrhythmogenic Right Ventricular Dysplasia 1,RNHF,Transforming growth factor beta-3 proprotein,ARVD
Phase de R&D la plus avancéePhase 2 Clinical
Nom anglaisTransforming growth factor beta 3
Alias de la cibleTransforming Growth Factor beta3,TGFB3,LAP,Prepro-Transforming Growth Factor Beta-3,TGF-Beta3,Transforming Growth Factor, Beta 3,ARVD1,LDS5,Arrhythmogenic Right Ventricular Dysplasia 1,RNHF,Transforming growth factor beta-3 proprotein,ARVD
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques3
Phase de R&D la plus avancéePhase 2 Clinical

TGF-beta 3 Liste de produits

  • Attribut

    Protein (3)

  • Bibliothèque de produits

    En ligne (3)

  • Espèces

    Human (3)

  • Étiquette

    Tag Free (1)His Tag & Avi Tag (1)His Tag (1)

  • Marqueur

    Unconjugated (2)Biotin-labeled (1)

Numéro de produitEspècesSystème d'expressionDescription du produitStructure protéiquePuretéCaractéristiquesPré-commande/Commande
Human
HEK293
Human TGF-beta 3 / TGFB3 Protein, premium grade
Ajouter au panier
Human
HEK293
Human Latent TGF-beta 3 / Latent TGFB3 Protein, His Tag
Ajouter au panier
Human
HEK293
Biotinylated Human Latent TGF-beta 3 / Latent TGFB3 Protein, His,Avitag™
Ajouter au panier
Quantité totale3
  • 1

TGF-beta 3Contexte de la molécule

Transforming growth factor beta 3 ( TGFB3) is also known as TGF-β3, is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including regulates embryogenesis and cell differentiation and is required in various processes such as secondary palate development. TGF-beta 3 is similar with TGF-beta 1 and ­-beta 2, act as cellular switches to regulate immune function, cell proliferation, and epithelial­-mesenchymal transition. TGF-beta-3 is released from LAP by integrins: integrin-binding results in distortion of the LAP chain and subsequent release of the active TGF-beta-3. Once activated following release of LAP, TGF-beta-3 acts by binding to TGF-beta receptors (TGFBR1 and TGFBR2), which transduce signal.

TGF-beta 3Alias de la molécule

TGFB3,ARVD,TGF-beta3

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
Dalutrafusp alfaGS-1423; AGEN-1423Phase 2 ClinicalAgenus IncCarcinoma, Pancreatic Ductal; Colorectal Neoplasms; Liver Neoplasms; Pancreatic Neoplasms; Solid tumours
Details
RG-6315RG-6315Phase 1 ClinicalGenentech IncScleroderma, Systemic
Details
BMS-986416BMS-986416; AVID-200 DP; AVID-200Phase 1 ClinicalFormation Biologics CorpPolycythemia Vera; Primary Myelofibrosis; Scleroderma, Diffuse; Solid tumours; Thrombocythemia, Essential
Details
  • Informations sur la molécule
  • Liste de produits
  • Informations sur les médicaments cliniques